{
    "Trade/Device Name(s)": [
        "Abbott Clinical Chemistry Creatinine",
        "Creatinine"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K061193",
    "Predicate Device Reference 510(k) Number(s)": [
        "K941837"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGX"
    ],
    "Summary Letter Date": "June 23, 2006",
    "Summary Letter Received Date": "April 28, 2006",
    "Submission Date": "April 26, 2006",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatine test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AEROSET System",
        "ARCHITECT c8000 System",
        "Hitachi 917 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Creatinine alkaline picrate methodology",
        "Photometric detection"
    ],
    "Methodologies": [
        "Quantitative analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Clinical Chemistry Creatinine assay for quantitative determination of creatinine in human serum, plasma, or urine using alkaline picrate methodology",
    "Indications for Use Summary": "Device measures creatinine in serum, plasma, and urine to aid in diagnosis and treatment of renal diseases, monitoring renal dialysis, and calculation of other urine analytes",
    "fda_folder": "Clinical Chemistry"
}